biotechnology

Gain Therapeutics Achieves Remarkable Breakthrough in Parkinson’s Disease Research

Source Node:
Time Stamp: August 29, 2023 8:20 AM - Modified On: August 29, 2023 - Published By:
Source Cluster:
Republished By Plato

Gain Therapeutics, Inc. (Nasdaq: GANX), a pioneering biotechnology company specializing in innovative allosteric small molecule therapies, has made significant strides in the fight against Parkinson's disease (PD). The Company's lead drug candidate, GT-02287, has demonstrated extraordinary potential in mitigating the effects of Parkinson's disease across two distinct preclinical models of the ailment. These findings suggest that GT-02287 has the capacity to alleviate Parkinson's disease pathology and enhance motor function. A notable highlight is the substantial reduction of plasma Neurofilament Light Chain (NfL) levels, an emerging biomarker for neurodegeneration. This advancement

Coya Therapeutics Reports Additional Biomarker and Imaging Data Showing Decrease in Neuroinflammation with COYA 301 in Alzheimer’s Disease.

Source Node:
Time Stamp: June 7, 2023 12:22 PM - Modified On: June 7, 2023 - Published By:
Source Cluster:
Republished By Plato

Highlights Coya reports new data illustrating that administration of COYA 301 (low dose Interleukin-2 (IL-2)) in an open- label study in 8 patients with mild to moderate AD (COYA 301 Trial) resulted in a statistically significant reduction in the expression of three well characterized proinflammatory cytokines -- Tumor Necrosis Factor alpha (TNF-α), Interleukin 6 (IL-6), and Interleukin 1- Beta (IL-1β) -- which correlated with lack of cognitive decline of the patients over the course of the study. TNF-α is one of the main inflammatory cytokines involved in initiating and propagating

Malaysian Genomics to Collaborate on Cannabinoid R&D

Source Node:
Time Stamp: February 24, 2023 7:08 AM - Modified On: February 24, 2023 - Published By:
Source Cluster:
Republished By Plato

Group joins MAHSA University and Kensana Health to develop phytopharmaceutical and biotechnology products for commercialisation PETALING JAYA, Malaysia, Feb 24, 2023 - (ACN Newswire) - Malaysian Genomics Resource Centre Berhad, a leading genomics and biopharmaceutical specialist, today announced that the Group has entered into a strategic collaboration with Kensana Health Canada and MAHSA University for the research and development (R&D) of phytopharmaceutical and biotechnology products that can lead to commercialisation. [caption id="attachment_1975650" align="alignnone" width="350"] Dato' Alvin Joseph Nesakumar, Executive Director of Malaysian Genomics[/caption] Kensana Health Canada is a biotechnology specialist

How to Restore Your Faith in Government

Source Node: https://www.bitcoinmarketjournal.com/how-to-restore-your-faith-in-government/
Time Stamp: August 18, 2020 5:47 PM - Modified On: May 21, 2021 - Published By:
Source Cluster:
Republished By Plato

Images courtesy of MIT Video Productions Here’s the announcement of the new blockchain education program with the Massachusetts state government. It’s a big deal. We have a vision for where this kind of partnership can go, when governments begin educating themselves on the power of bitcoin and blockchain. That vision can be summed up in two words: Kendall Square. Kendall Square, then. The Kendall Square neighborhood lies next to the Massachusetts Institute of Technology, stretching along the Charles River that separates Cambridge from Boston. (Here’s a map.) Although you’d think

How to Make Things Go Viral: Learn From Coronavirus

Source Node: https://www.bitcoinmarketjournal.com/how-to-make-things-go-viral/
Time Stamp: April 7, 2020 6:13 PM - Modified On: May 21, 2021 - Published By:
Source Cluster:
Republished By Plato

When an idea catches on, what do we call it? “Going viral.” In the age of Coronavirus, we need good messages to go viral. Whether you’re running a business, an organization, or a family, you need good messages to go viral. As a society, we must encourage people to #SlowTheSpread and help our #HealthcareHeroes: we need good messages to go viral. But how do we help good messages to go viral, faster than the virus itself? We spent some time digging into virology research papers, and we have some good